Iovance Biotherapeutics (IOVA) Other Operating Expenses (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Other Operating Expenses of $51.0 million for Q1 2026, up 0.51% year-over-year from $50.8 million in Q1 2025, and down 3.1% quarter-over-quarter from $52.7 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Other Operating Expenses (2010 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Other Operating Expenses for 8 consecutive years, with $51.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Operating Expenses rose 0.51% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $207.9 million (down 13.7% YoY), while the FY2025 annual figure was $209.2 million, up 59.85% from the prior year.
- Other Operating Expenses declined to $51.0 million in Q1 2026 per IOVA's latest filing, from $52.7 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $117.4 million in Q4 2024 and bottomed at $2.0 million in Q2 2023.
- Historically, Other Operating Expenses has averaged $39.9 million across 4 years, with a median of $44.4 million in 2024.
- Annual changes were most pronounced in 2024 — Other Operating Expenses soared 1430.15% — and 2025, when it sank 55.15%.
- Iovance Biotherapeutics' Other Operating Expenses stood at $16.1 million in 2023, then jumped by 631.04% to $117.4 million in 2024, then tumbled by 55.15% to $52.7 million in 2025, then decreased by 3.1% to $51.0 million in 2026.
- Business Quant data shows IOVA's Other Operating Expenses at $51.0 million in Q1 2026, $52.7 million in Q4 2025, and $47.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 53.10 Mn |
| Mar 31, 2026 | 51.04 Mn |
| Dec 31, 2025 | 52.67 Mn |
| Sep 30, 2025 | 47.48 Mn |
| Jun 30, 2025 | 56.66 Mn |
| Mar 31, 2025 | 50.78 Mn |
| Dec 31, 2024 | 117.45 Mn |
| Sep 30, 2024 | 41.25 Mn |
| Jun 30, 2024 | 31.37 Mn |
| Mar 31, 2024 | 7.26 Mn |
| Dec 31, 2023 | 16.07 Mn |
| Sep 30, 2023 | 4.34 Mn |
| Jun 30, 2023 | 2.05 Mn |
| Dec 31, 2020 | 191.73 Mn |
| Dec 31, 2012 | 1.22 Mn |
| Sep 30, 2012 | 1.38 Mn |
| Jun 30, 2012 | 1.38 Mn |
| Mar 31, 2012 | 2.25 Mn |
| Dec 31, 2011 | 3.46 Mn |
| Sep 30, 2011 | 5.81 Mn |